drugset / Trial / NCT00218517

Effectiveness of Selegiline in Treating Marijuana Dependent Individuals - 1

NCT00218517

Phase 2 Completed 19 enrolled National Institute on Drug Abuse (NIDA)
RandomizedParallel-groupDouble-blindTreatment

Summary

During the past 15 years, the demand for treatment for marijuana-related problems in the United States has increased nearly twofold. Selegiline is a medication currently used to treat nicotine dependence. The purpose of this study is to evaluate whether selegiline may be useful in treating individuals with marijuana dependence.

Timeline

Start
2005-03
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Selegiline Unknown 5 mg Oral

Indications